Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs17007417
rs17007417
T 0.700 GeneticVariation GWASCAT Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. 29385134

2018

dbSNP: rs8099917
rs8099917
0.030 GeneticVariation BEFREE For HCV-genotype 1 patients, rs12980275 A and rs8099917 T alleles decreased the odds for liver steatosis (OR = 0.22; p < 0.001 and OR = 0.39; p = 0.048; respectively). 23103287

2013

dbSNP: rs8099917
rs8099917
0.030 GeneticVariation BEFREE No association between PNPLA3 rs738409/IL28B rs8099917 genotypes and hepatic steatosis or liver fibrosis was observed. 24349054

2013

dbSNP: rs8099917
rs8099917
0.030 GeneticVariation BEFREE Rs12979860 TT or rs8099917 GG genotypes as well as markers of serum and hepatocyte iron overload associated with higher activity of gamma-glutamyl transpeptidase and liver steatosis. 27125837

2017

dbSNP: rs12743824
rs12743824
0.010 GeneticVariation BEFREE The rs12743824 and rs738491 SNPs were independently associated with FLD and steatohepatitis, respectively. 26352879

2015

dbSNP: rs12980275
rs12980275
0.010 GeneticVariation BEFREE For HCV-genotype 1 patients, rs1</span>2980275 A and rs8099917 T alleles decreased the odds for liver steatosis (OR = 0.22; p < 0.001 and OR = 0.39; p = 0.048; respectively). 23103287

2013

dbSNP: rs13361189
rs13361189
0.010 GeneticVariation BEFREE In our community-based, longitudinal cohort of Caucasian adults, variants in the autophagy-governing IRGM gene at the rs13361189 locus were not associated with increased prevalent or incident HS. 30597691

2019

dbSNP: rs3865188
rs3865188
0.010 GeneticVariation BEFREE Conversely, the rs3865188 variant, associated with a lower OR for T2D, was also associated with lower BMI (P=0.03), HbA<sub>1c</sub> (P=0.02) and Fatty Liver Index (FLI; P≤0.01), and higher plasma adiponectin levels (P=0.002). 27289142

2017

dbSNP: rs6834314
rs6834314
0.010 GeneticVariation BEFREE The minor allele of rs6834314 was significantly associated with increased steatosis but decreased inflammation, ballooning, Mallory-Denk bodies, and liver enzyme levels in 768 adult Caucasians with biopsy-proven NAFLD and with cirrhosis in the general population. 30415504

2019

dbSNP: rs1229984
rs1229984
0.010 GeneticVariation BEFREE Genetic polymorphisms of alcohol dehydrogenase-1B (ADH1B; rs1229984, His48Arg) and aldehyde dehydrogenase-2 (ALDH2; rs671, Glu504Lys) affect body weight, body fat, and lipid metabolism in individuals with alcohol dependence, and the aim of this study was to identify their determinants in relation to the development of fatty liver. 29063269

2018

dbSNP: rs2241766
rs2241766
0.010 GeneticVariation BEFREE The presence of the ADIPOQ rs2241766 G allele (GG/GT genotype) was associated with a protective effect against dyslipidemia, primarily in HIV/HCV-coinfected patients with steatosis. 24528335

2014

dbSNP: rs1042714
rs1042714
0.010 GeneticVariation BEFREE Univariate analysis indicated that subjects with the heterozygous Gln27Glu mutant alleles had a significantly higher prevalence of fatty liver vs. those without the mutation (Glu27 allele frequency, 0.07 vs. 0.12, p=0.047; odds ratio, 1.92; 95% confidence interval, 1.01-3.68). 11718682

2001

dbSNP: rs671
rs671
0.010 GeneticVariation BEFREE Genetic polymorphisms of alcohol dehydrogenase-1B (ADH1B; rs1229984, His48Arg) and aldehyde dehydrogenase-2 (ALDH2; rs671, Glu504Lys) affect body weight, body fat, and lipid metabolism in individuals with alcohol dependence, and the aim of this study was to identify their determinants in relation to the development of fatty liver. 29063269

2018

dbSNP: rs940553638
rs940553638
0.010 GeneticVariation BEFREE Genetic polymorphisms of alcohol dehydrogenase-1B (ADH1B; rs1229984, His48Arg) and aldehyde dehydrogenase-2 (ALDH2; rs671, Glu504Lys) affect body weight, body fat, and lipid metabolism in individuals with alcohol dependence, and the aim of this study was to identify their determinants in relation to the development of fatty liver. 29063269

2018

dbSNP: rs1553403917
rs1553403917
CA 0.700 CausalMutation CLINVAR A Next Generation Sequencing custom gene panel as first line diagnostic tool for atypical cases of syndromic obesity: Application in a case of Alström syndrome. 29079548

2018

dbSNP: rs2854116
rs2854116
0.020 GeneticVariation BEFREE The PNPLA3, but not the APOC3 rs2854116 SNP, was associated with fatty liver but not with triglyceride levels. 22105854

2012

dbSNP: rs2854116
rs2854116
0.020 GeneticVariation BEFREE By multivariable Cox analysis, concurrent fatty liver (HR 7.27, 95% confidence interval: 1.52-34.76; P = 0.013), age, cirrhosis, and APOC3 rs2854116 TC/CC genotype (HR 3.93, 95% confidence interval: 1.30-11.84; P = 0.013) were independent factors predicting HCC development. 27547913

2017

dbSNP: rs2070666
rs2070666
0.010 GeneticVariation BEFREE The APOC3 rs2070666 A allele was linked to the fourth quartile of the controlled attenuation parameter values (OR 2.769, 95 % CI 1.002-7.651) in 131 subjects, and also linked to the significant histological steatosis (OR 4.986, 95 % CI 1.020-24.371), but neither to liver stiffness measurement values nor to hepatic histological activity and fibrosis in NAFLD patients. 27059980

2016

dbSNP: rs74315468
rs74315468
0.010 GeneticVariation BEFREE The aim of this study was to investigate the relation between liver steatosis with plasma homocysteine level and MTHFR C677T and A1298C polymorphisms in Brazilian patients with NAFLD. 23547829

2013

dbSNP: rs886041065
rs886041065
T 0.700 CausalMutation CLINVAR

dbSNP: rs1800777
rs1800777
0.010 GeneticVariation BEFREE A variant of the polymorphism rs1800777 of CETP gene is independently associated with the presence of steatosis and lobulillar inflammation in subjects with proven biopsy NAFLD. 30293065

2018

dbSNP: rs3213445
rs3213445
0.010 GeneticVariation BEFREE Carriers of the rare CPT1b 66V (rs3213445) allele had significantly higher γ-glutamyl transpeptidase (GGT), glutamic oxaloacetic transaminase (GOT) and glutamic pyruvate transaminase (GPT) activities (P< 0·0001, P= 0·03 and P= 0·048, respectively) and a higher fatty liver index (FLI, P= 0·026). 22809552

2013

dbSNP: rs12784396
rs12784396
0.010 GeneticVariation BEFREE Nine variants (rs2862954, rs1408579, rs10883451, rs11597086, rs11591741, rs17729876, rs17668255, rs17668357, rs12784396) displayed genomewide significant associations at loci concomitantly influencing FL and ALT (2.47 × 10(-9) ≤ CMA-p ≤ 4.29 × 10(-10)) as compared with the suggestive significance of marginal tests (4.11 × 10(-5) ≤ GWA-p ≤ 2.34 × 10(-6)). 23477746

2013

dbSNP: rs1554888939
rs1554888939
T 0.700 GeneticVariation CLINVAR

dbSNP: rs2862954
rs2862954
0.010 GeneticVariation BEFREE For example, the missense variant in ERLIN1-rs2862954 was genomewide significant (CMA-p = 4.88 × 10(-10)) for the combination of FL and ALT, while the respective univariate associations were suggestive (FL:p = 5.74 × 10(-6), ALT:p = 3.71 × 10(-6)). 23477746

2013